Furthermore, COVID-19 patients have elevated levels of von Willebrand factor (VWF) antigen, VWF activity, and factor VIII [112], leukocytosis, thrombocytopenia, increased partial thromboplastin time, and low levels of antithrombin activity [113]. The gene discussed is VWF; the disease is Increased total leukocyte count.